Jefferies Financial Group Reduces Stake in IDEXX Laboratories

The financial services firm sold 1,173 shares of the veterinary diagnostics company in the third quarter.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Jefferies Financial Group Inc. reduced its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 5.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm now owns 20,465 shares of the company's stock, valued at $13,075,000 at the end of the quarter.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. As a major institutional investor, Jefferies Financial Group's stake reduction could signal a shift in market sentiment around the company's performance or growth prospects.

The details

In the 3rd quarter, Jefferies Financial Group sold 1,173 shares of IDEXX Laboratories, reducing its total position to 20,465 shares. The firm cited the company's stock price performance and market conditions as factors behind the decision to trim its stake. IDEXX's shares have seen volatility in recent months, with the stock trading between a 52-week low of $356.14 and a high of $769.98.

  • Jefferies Financial Group reduced its IDEXX Laboratories stake in the 3rd quarter of 2026.

The players

Jefferies Financial Group Inc.

A global financial services firm that provides investment banking, capital markets, and asset management services.

IDEXX Laboratories, Inc.

A leading provider of diagnostic products and services for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

Jefferies Financial Group's reduction in its IDEXX Laboratories stake could signal a shift in market sentiment around the veterinary diagnostics company's performance or growth prospects, though the reasons behind the decision are not entirely clear from the available information.